May 1 Lion Biotechnologies Inc:
* Q1 loss per share $0.33
* Q1 adjusted loss per share $0.28
* Q1 earnings per share view $-0.28 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
CORRECTED-UPDATE 1-Seattle Genetics, Takeda lymphoma drug success fails to impress investors
June 26 Seattle Genetics Inc and Japan's Takeda Pharmaceutical Co Ltd said on Monday that their drug met the main goal in a late-stage study of helping blood cancer patients live longer without their condition worsening.